Integrated Sciences IV: Hematologic/Oncology
This course will focus on integrating pathophysiologic mechanisms with the pharmacotherapeutic interventions used in the management of hematologic and oncologic disorders, including but not limited to anemias, coagulation disorders, sickle cell disease, breast cancer, lung cancer, colorectal cancer, prostate cancer, lymphomas, ovarian cancer, acute and chronic leukemias, and melanoma.
Course Details
YEAR 3 - Semester 2
PHAR 856 (formerly PHAR 556)
3 units



Current Students